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a b s t r a c t 
Introduction: Pharmacists in low-middle-income countries (LMIC) are few and lack antibiotic steward- 
ship (AS) training. The ability was assessed of non-specialised pharmacists to implement stewardship in- 
terventions and improve adherence to the South African community-acquired pneumonia (CAP) guideline 
in public and private hospitals. 
Methods: This was a multicentre, prospective cohort study of adult CAP patients hospitalised between 
July 2017 and July 2018. A CAP bundle was developed of seven process measures (diagnostic and AS) that 
pharmacists used to audit compliance and provide feedback. CAP bundle compliance rates and change in 
outcome measures [mortality, length of stay (LOS) and infection-related (IR)-LOS] during pre- and post- 
implementation periods were compared. 
Results: In total, 2464 patients in 39 hospitals were included in the final analysis. Post-implementation, 
overall CAP bundle compliance improved from 47 ·8% to 53 ·6% (confidence interval [CI] 4 ·1-7 ·5, p < 0 ·0 0 01), 
diagnostic stewardship compliance improved from 49 ·1% to 54 ·6% (CI 3 ·3-7 ·7, p < 0 ·0 0 01) and compliance 
with AS process measures from 45 ·3% to 51 ·6% (CI 4 ·0-8 ·6, p < 0 ·0 0 01). Improved compliance with process 
measures was significant for five (2 diagnostic, 3 AS) of seven components: radiology, laboratory, antibi- 
otic choice, duration and intravenous to oral switch. There was no difference in mortality between the 
two phases, [4 ·4%(55/1247) vs. 3 ·9%(47/1217); p = 0 ·54], median LOS or IR LOS 6 ·0 vs. 6 ·0 days (p = 0 ·20) 
and 5 ·0 vs. 5 ·0 days (p = 0 ·40). 
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Community-acquired pneumonia (CAP) is a significant cause 
f global morbidity and mortality [1] . Antibiotic stewardship 
rograms (ASPs) are recommended to ensure appropriate use 
f antibiotics, which are a cornerstone of therapy for CAP 
2] . 
The South African Thoracic Society and the Federation of In- 
ectious Diseases Societies of Southern Africa updated the CAP 
uideline in 2017 [3] . Adherence to CAP guidelines has the po- 
ential to limit selection of antibiotic resistance, decrease health- 
are costs, and reduce patient mortality [3] . Documenting com- 
liance with national CAP guidelines is an important component 
f ASPs as this can elucidate where interventions are necessary 
4] . Sustainable and effective ASPs depend on teamwork to iden- 
ify and implement interventions, and develop organisational in- 
rastructure [5 , 6] . Previous studies of compliance with CAP guide- 
ines in South Africa (SA) were single-site, retrospective stud- 
es in public-sector hospitals and no interventions were included 
7-9] . 
In the South African context, particularly in the public sector, it 
s difficult to replicate resource-abundant stewardship models [10] . 
tilising pharmacists as antibiotic stewards in low and middle in- 
ome countries (LMICs) is challenging because pharmacists have 
o specialist infectious diseases or ASP training and are generally 
imited to dispensing roles [11-13] . 
However, previous successful pharmacist-led stewardship in- 
erventions highlight the role pharmacists can play as stewards 
14–16] . In these multicentre studies, non-specialist private-sector 
harmacists in SA were allocated one hour a day for steward- 
hip interventions and used the breakthrough-series collaborative 
ethod for shared learning [14–16] . An important question is 
hether pharmacist-led stewardship interventions would work in 
he SA public sector, where 80% of the population receives health- 
are, and which faces even more intense human resource and 
ealth system challenges. Additionally, there was an opportunity to 
xplore whether a stewardship intervention could be co-ordinated 
cross public- and private-sector hospitals. 
The current study was initiated by the South African Antibiotic 
tewardship Programme (SAASP), which provides leadership, ad- 
ocacy for, and strengthening of, antibiotic stewardship across SA 
17] . The primary objective of this study was to assess the utiliza- 
ion of non-specialised pharmacists in both public and private hos- 
itals to implement community-acquired pneumonia (CAP) stew- 
rdship interventions. 2 armacists in public and private hospitals implemented stewardship inter-
ance to SA CAP guidelines. The methodology of upskilling and a shared
y benefit LMIC countries. 
© 2020 The Authors. Published by Elsevier Ltd. 
This is an open access article under the CC BY-NC-ND license
( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) 
. Methods 
.1. Settings 
This was a multicentre, pharmacist-led prospective study of a 
onvenience sample of adult patients admitted to a public or pri- 
ate hospital for CAP between July 2017 and July 2018. No incen- 
ives were provided to encourage pharmacists to participate. 
.2. Ethics 
Ethics approval was obtained from Sefako Makgatho 
niversity Research Ethics Committee (registration number 
MUREC/H/262/2016). This approval was used to obtain approval 
rom research governance structures at each participating public- 
nd private-sector hospital. All study data were anonymised, with 
o unique identifiers recorded. 
.3. Community-acquired pneumonia antibiotic stewardship model 
The SA CAP guideline was used to create a CAP bundle that 
harmacists followed to audit compliance with defined diagnos- 
ic and antibiotic treatment criteria. The core process (n = 7) and 
utcome (n = 3) measures for pharmacist audit and feedback are 
ummarised in Table 1 . Implementation of the CAP stewardship 
odel ( Fig. 1 ) was based on the Breakthrough Series Collabora- 
ive [18] and Institute of Healthcare Improvement (IHI) Model [19] , 
dapted as previously described [14–16] . 
A leadership team of seven experienced SA pharmacist stew- 
rds representing private and public sectors was formed to lead the 
tudy, including design of workshop content, facilitation of learn- 
ng sessions, recruitment of pharmacists, and provision of support 
o participating pharmacists. The team was supported by four SA 
linical and ASP advisors who were specialists in one each of the 
ollowing disciplines; infectious diseases (ID), intensive care, pul- 
onology, and clinical microbiology, and in addition one ID phar- 
acist from the United States of America. 
The content for training pharmacists in antibiotic stewardship 
kills for each phase of the study is summarised in Table 2 . 
ach pharmacist attended three learning sessions. If sessions were 
issed, a study leader provided one-on-one training. After each 
earning session, a checklist of essential activities and deadlines 
as provided to each pharmacist. 
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Table 1 
Process and outcomes measures for national pharmacist-led community-acquired pneumonia stewardship model. 
DEFINITION OF COMMUNITY ACQUIRED PNEUMONIA [28] 
Pneumonia is an acute infection of the lung parenchyma distal to the terminal bronchiole, most commonly bacterial in nature, and associated with clinical and/or radio- 















. Study Design 
.1. Phase 1: Call to action 
This phase commenced in February 2016 at an SAASP meeting 
here the first call-to-action was made to engage pharmacists in 
he national SAASP Pharmacist CAP stewardship study. The level of 
nterest expressed provided the impetus to establish the leadership 
tructure, organise expert clinical and antibiotic stewardship advi- 
ors, develop a formal protocol and enrol pharmacists. 
Pharmacists were required to commit to: 
• obtaining approval from their pharmacy and hospital man- 
ager 
• attending the three SAASP CAP study training sessions 3 • completing the field work required for the study after each 
session 
• providing timely, accurate and complete data to their allo- 
cated leader 
• building relationships with multidisciplinary team members 
to support the study 
Although the 2007 SA CAP guidelines were not yet updated dur- 
ng the initial call to action in 2016, clinical advisors for this study 
ere part of the SA CAP guideline Working Group and kept the 
tudy leaders informed of the publication date. Pharmacists were 
rovided with the South African 2007 guideline during the call to 
ction (February 2016) and the updated version was distributed 
lectronically to all pharmacists enrolled in the study when it was 
ublished in June 2017. The criteria measured in the current study 
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Fig. 1. South African Antibiotic Stewardship Programme (SAASP) Community Acquired Pneumonia (CAP) stewardship “Breakthrough Series Collaborative” Antimicrobial stew- 


















































ere the same as the 2007 guideline, except for small changes re- 
arding alternative antibiotic treatment. 
.2. Phase 2: Baseline compliance 
Following the first learning session in late July 2017, eight 
eeks of baseline compliance data ( Table 1 ) were collected on 
tandardised daily sheets, then collated using a Microsoft Excel TM 
emplate and submitted to study leaders. 
Pharmacists determined the most common wards to which CAP 
atients were admitted and identified these patients daily during 
ormal working hours in the time allocated for the study. Patients 
ith CAP were identified through a physician-determined admis- 
ion diagnosis of CAP entered onto the patient charts. Pharmacists 
dentified these cases by reviewing the charts and recruited CAP 
atients into the study in real-time during weekdays and retro- 
pectively when the admission occurred over weekends or holi- 
ays. 
.3. Phase 3: Intervention 
In the four-week period after learning session 2, pharmacists 
pplied the ideas that had been generated to improve compliance 
nd ways to give feedback to admitting physicians to facilitate im- 
lementation of interventions. Each pharmacist used their base- 
ine data to identify gaps and intervened accordingly. During this 
hase, pharmacists engaged prospectively with multi-disciplinary 
eam members and hospital leadership to drive improved compli- 
nce. 
.4. Phase 4: Post-intervention 
Each participating pharmacist continued with prospective re- 
iews of the cases, and with feedback and data collection for a fur- 4 her 21 weeks. The seven study leaders provided support either in 
erson or by telephone and supervised regular follow-up of data. 
.5. Process and outcome measurement 
Compliance to process measurements were calculated as per- 
entages relative to the number of CAP patients enrolled, with the 
enominator the number of patients reviewed, and the numera- 
or those who were compliant with each of the seven CAP process 
ompliance measures. Process compliance data were further di- 
ided into diagnostic (n = 3) and antibiotic stewardship (n = 4) mea- 
ures. 
The three outcomes measures used for the study comprised in- 
ospital mortality, length of stay (LOS) and infection-related LOS 
IR-LOS). However, 30-day readmission rates were not measured. 
Although the starting date for each hospital was not the same, 
harmacists collected eight weeks of baseline data. They then al- 
owed four weeks for interventions and after that continued to 
onitor/measure for 21 weeks post-intervention. The weeks for 
ach hospital were aligned (i.e. Week 1 at hospital 1 = Week 1 
t Hospital 2 etc.) even though the dates may have been weeks 
part. 
.6. Data analysis 
To assess the pre- vs. post-implementation changes in compli- 
nce with the guideline, statistical analyses were conducted on 
ooled data and according to the pre-specified statistical plan. 
ample size estimation was based on the key research question, 
iz. the detection of a 10% (absolute) improvement in any given 
ompliance criterion from 50% to 60% from Phase 2 to Phase 4. Us- 
ng the 5% significance level, and a power of 80%, a total minimum 
ample size of 808 (404 per Phase) was required. 
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Table 2 
Learning session content for upskilling pharmacists and shared learning in pharmacist-led community-acquired pneumonia 
stewardship model. 




































Compliance scores (diagnostic, stewardship and overall) were 
etermined by calculating mean compliance with the relevant cri- 
eria for each patient. Compliance with the seven measures and 
verall composite compliance over the eight-week baseline (Phase 
) was compared with the 21 weeks post-intervention (Phase 4). 
ata from patients reviewed during the implementation of inter- 
entions (Phase 3) was not included in the outcomes measure- 
ent. 
For hospitals that participated in all phases of the study, where 
 patient had missing data it was removed from the denominator 
nd numerator. 
The following study variables were compared between phases: 
ex, ward, comorbidities, compliance with criteria, and mortality 
sing the z-test for proportions. CURB-65 score was compared us- 
ng the chi-squared test. Age and compliance scores were com- 
ared using the t-test for independent samples. Where the as- 
umptions of this test were not met, the non-parametric Wilcoxon 
ank sum test was used. Change in outcome measures, includ- 
ng in-hospital mortality, LOS and IR-LOS, were performed us- 
ng the z-test; however, the study was not powered to detect a 
ifference. 
The relationship between each compliance score and phase, af- 
er controlling for hospital sector, age, sex, ward, CURB-65 score f
5 nd LOS, was determined using the General Linear Model (GLM) 
ith compliance score as the dependent variable, and phase and 
he listed covariates as independent variables. 
.7. Role of funding source 
The study was partly funded by a grant from Merck. The re- 
aining costs were covered by volunteer contributions of time. 
he funders of the study had no role in study design, data collec- 
ion, data analysis, data interpretation or writing of the report. The 
orresponding author had full access to all the data in the study 
nd had final responsibility for the decision to submit for publica- 
ion. 
. Results 
.1. Participating pharmacists 
A total of 63 pharmacists, 55 from private and 8 from public- 
ector hospitals, participated in the full study. Six pharmacists 
ithdrew due to insufficient dedicated stewardship time result- 
ng from staff shortages, two from the private sector and four 
rom the public sector. The majority of the 69 original pharmacists 
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Table 3 
Patient demographics for national pharmacist-led community-acquired pneumonia stewardship model: Comparison of Phase 2 and 4. 
Variable Category Phase 2 Phase 4 Comparison of Phase 2 and 4 
n % n % P -value Difference 
Phase 4 and 2 
95% CI for difference 
Total Patients 1247 100 1217 100 
Patients per sector Private 1067 85 ·6 1026 84 ·3 
Public 180 14 ·4 191 15 ·7 0 ·40 1 ·3 -1 ·6 4 ·1 
Age (years) 18-64 696 55 ·8 709 58 ·3 0 ·22 
65 + 551 44 ·2 508 41 ·7 -2 ·4 -6 ·4 1 ·5 
Mean overall 1247 60 ·0 1217 58 ·3 0 ·027 -1 ·7 3 ·2 0 ·2 
Sex Female 762 61 ·1 705 57 ·9 0 ·11 
Male 485 38 ·9 512 42 ·1 3 ·2 -0 ·7 7 ·1 
Ward General ward 1024 82 ·1 999 82 ·1 > 0 ·99 
ICU/High care 223 17 ·9 218 17 ·9 0 ·0 -3 ·0 3.1 
CURB-65 score 0 392 31 ·4 391 32 ·1 0 ·36 
1 357 28 ·6 376 30 ·9 
2 322 25 ·8 272 22 ·4 
3 138 11 ·1 139 11 ·4 
4/5 38 3 ·0 39 3 ·2 






































































ad a bachelor’s degree in pharmacy (65%; n = 45) and 35% (n = 24)
ad enrolled for, or completed, a master’s degree. Most pharma- 
ists (59%; n = 41) had between 5 and 14 years of work experience.
hirty-nine percent of pharmacists had less than three years of an- 
ibiotic stewardship experience and 7% had none. The majority had 
o research experience, although 19 private-sector pharmacists had 
revious experience with the study methodology. 
.2. Hospital demographics 
Forty-five hospitals, including 36 private and 9 public-sector 
ospitals, across eight of nine provinces in SA, initially enrolled in 
he study. Six of the 45 were subsequently excluded due to phar- 
acists withdrawing and data not being available for all phases. 
verall, 39 hospitals (six public, 33 private) completed the study. 
our hospitals had less than 100 beds, 20 hospitals had 100–249 
eds, 12 had 250–499 beds, and three hospitals had 800–1652 
eds. Eight hospitals were located outside of main urban cities. 
.3. Patient Demographics 
A total of 3117 patients were reviewed between July 2017 and 
uly 2018. Of these, 2464 were included in the final analysis. This 
ncluded 1247 patients from Phase 2 (baseline) that were com- 
ared to 1217 patients from Phase 4 (post-intervention). Patients 
rom the six hospitals where the pharmacists withdrew from the 
tudy were excluded (n = 47). The 606 patients reviewed in Phase 
 (intervention phase) were also not analysed as this was the time 
n which pharmacists implemented interventions to improve com- 
liance. 
Patient demographics in Phases 2 and 4 are shown in Table 3 . 
here was no significant difference in the public/private hospital 
ype ( P = 0.40) between the two phases, nor in ward composition 
ICU/high care vs. general ward) ( P > 0.99) and/or sex composition 
 P = 0.11). The mean patient age in Phase 2 (60.0 ±1.1yrs) was sig-
ificantly higher than in Phase 4 (58.3 ±1.1yrs) (P = 0.027). There 
as no significant difference in distribution of CURB-65 scores. 
he difference in patient numbers in Phase 2 and Phase 4 was 
ttributed to the seasonality of CAP with Phase 2 taking place in 
inter months. 
.4. Process measures 
Comparing Phase 2 and Phase 4, compliance with diagnos- 
ic measures improved from 49.1% to 54.6% ( P < 0.0 0 01), antibiotic6 tewardship measures from 45.3% to 51.6% ( P < 0.0 0 01), and overall 
omposite compliance from 47.8% to 53.6% ( P < 0.0 0 01) ( Table 4 ).
here was a significant increase in compliance from Phase 2 to 
hase 4 for the following individual measures: radiology, micro- 
iology cultures, antibiotic choice, duration of therapy and intra- 
enous (IV) to oral switch. 
.5. Outcomes measures 
There was no significant difference between Phases 2 and 4 in 
verall in-hospital mortality (4.4% vs. 3.9%; P = 0.54), total median 
OS (6.0 vs. 6.0 days; P = 0.20) or median IR-LOS (5.0 vs. 5.0 days;
 = 0.40). 
.6. Differences in private- and public-sector outcomes 
Fig. 2 shows the public vs. private guideline compliance to 
he process and outcome measures. Mean overall compliance in- 
reased in both public (55.6% to 66.3%; P < 0.0 0 01) and private 
46.5% to 51.2%; P < 0.0 0 01) sectors although the differences in the 
rivate sector were smaller. The greatest improvements were in 
he public-sector hospitals for compliance to laboratory guidelines 
21.1% in Phase 2 vs. 38.2% in Phase 4) and antibiotic choice (51.7% 
n Phase 2 vs. 72.8% in Phase 4). This represents a 17.1% and 21.1% 
mprovement (95% CI 8.0-26.2 and 11.5-30.8). 
LOS and IR LOS were higher in the public sector in Phase 1 but 
qualised after the intervention phase with no change in the pri- 
ate sector. Public sector median LOS decreased significantly (from 
 to 6 days; P = 0.0 0 05) between Phase 2 and Phase 4. Mortality
id not improve significantly in either sector as shown in Fig. 2 . 
Private-sector pharmacists reviewed a mean of 38 patients per 
harmacist in Phases 2 and 4, whereas public-sector pharmacists 
eviewed a mean of 46 patients per pharmacist. 
Diagnostic compliance score was significantly higher for older 
atients, in public hospitals, in ICU/high care wards, for CURB 
cores > 0, and for longer LOS. The stewardship compliance score 
as significantly higher for females, in public hospitals, in gen- 
ral wards, for CURB-65 score of 3, and for shorter LOS. The 
verall compliance score was significantly higher for female pa- 
ients, in public hospitals, and for CURB-65 scores > 0. However, 
one of these factors detracted from the improvement in com- 
liance score between Phases 2 and 4 (compared to unadjusted 
esults). 
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Table 4 
Compliance to CAP process measures between pre- (Phase 2) and post- (Phase 4) implementation. 
Variable Process 
measure 
Phase 2 (n = 1247) Phase 4 (n = 1217) 
n % n % P -value  % 95% CI for difference 
Diagnostic measures Radiology 752 60 ·3 831 68 ·3 < 0 ·0001 ∗ 8 ·0 4 ·2 11 ·8 
X-ray done (n = 2463) 1138 91.3 1113 91.5 0.83 0.3 -1.9 2.5 
X-ray report stated CAP 765 61.3 835 68.6 0.0002 7.3 3.5 11.0 
Admission criteria 899 72 ·1 893 73 ·4 0 ·50 1 ·3 -2 ·2 4 ·8 
Microbiology cultures 185 14 ·8 269 22 ·1 < 0 ·0001 ∗ 7 ·3 4 ·2 10 ·3 
Overall mean compliance to diagnostic measures (composite score) 1247 49 ·1 1217 54 ·6 < 0 ·0001 ∗ 5 ·5 3 ·3 7 ·7 
Antibiotic measures Choice 686 55 ·0 773 63 ·5 < 0 ·0001 ∗ 8 ·5 4 ·6 12 ·4 
Dose (n = 1453/1459) a 628 91 ·5 725 94 ·2 0 ·065 2 ·6 -0 ·1 5 ·3 
Duration (n = 2452) a 624 50 ·3 666 55 ·0 0 ·024 ∗ 4 ·6 0 ·7 8 ·6 
IV to oral switch (n = 2450) a 202 16 ·3 237 19 ·7 0 ·031 ∗ 3 ·4 0 ·3 6 ·4 
Overall mean compliance to antibiotic measures (composite score) 45 ·3 51 ·6 < 0 ·0001 ∗ 6 ·3 4 ·0 8 ·6 
Overall mean CAP 
bundle compliance 
(composite score) 
All 47 ·8 53 ·6 < 0 ·0001 ∗ 5 ·8 4 ·1 7 ·5 
∗ Denotes significant difference. 
a - Different denominators reflects pharmacists’ review of CAP patients on more than one antibiotic. 

































This pharmacist-driven, antibiotic stewardship implementation 
tudy measuring compliance to a CAP guideline bundle in both 
ublic- and private-sector hospitals showed an overall improve- 
ent in both diagnostic and antibiotic measures. 
The strength of this study is that it represents the first collab- 
ration between public and private-sector hospitals in antibiotic 
tewardship and is, to the best of our knowledge, a novel multi- 
entre study involving both sectors in an LMIC. 
Private-sector pharmacists in SA have previously demonstrated 
uccess in stewardship interventions [14-16] . It was an important 
ational goal to have representation from both public- and private- 
ector hospitals because 80% of health care delivery in SA is via the 
ublic sector. 
Previous SA studies of CAP compliance were performed in sin- 
le public-sector hospitals, used older versions of the SA CAP 
uideline (1996 [7] and 2007 [8 , 9] ) and showed compliance as low7 s 8%. The current study showed modest improvement in guideline 
dherence over the 21 weeks and recognised opportunities for fur- 
her improvement in compliance. Compliance data evaluating pro- 
ess measures are not routinely available in SA, although they are 
ncreasingly needed. Data on defined process and outcomes mea- 
ures for CAP in these two hospital sectors enables identification 
nd target of practice areas for improvement. Although the clin- 
cal significance of such improvement is unclear, the stewardship 
nterventions by public- and private-sector pharmacists remain an 
mportant factor, particularly as previous SA CAP studies showed 
on-compliance was due to overtreatment with antibiotics rather 
han undertreatment. An Australian study using electronic medi- 
al records showed lower overall compliance to antibiotic guide- 
ines for CAP in the public sector and recommend increased time 
or pharmacists to perform stewardship duties in the private sec- 
or, amongst other interventions [20] . A retrospective study in the 
nited States using a Medicare database identified that improved 
uration of therapy in CAP patients offered an opportunity for na- 
























































































































ional antibiotic stewardship efforts [21] . The current study was 
rospective with pharmacist-led interventions that resulted in im- 
roved compliance including duration. 
The inclusion of diagnostic stewardship criteria was an impor- 
ant addition to conventional pharmacist interventions. Pharma- 
ists recorded whether a chest X-ray was performed and, if so, 
hether the radiology report indicated the presence of CAP. As 
hown in Table 4 , there was no difference in the percentage of X-
ays requested but this was already above 90% in the first phase. 
fter the interventions, there was a significant difference in X-ray 
eports that confirmed CAP in Phase 4. Pharmacists also measured 
ompliance with guidelines for the performance of microbiological 
esting and used the test results to determine compliance with the 
hoice of antibiotic and to recommend changes to treatment, as 
equired. Compliance with both these process measures improved 
rom Phase 2 to Phase 4 (see Table 4 ). 
A study by the British Thoracic Society (BTS) [22] attributed 
oor CAP guideline compliance to insufficient timeframes for 
hange, stating that up to two years is needed. Two further factors 
ay have contributed to the lack of clinical benefit in the current 
tudy despite increased compliance with CAP guidelines. Firstly, in 
he BTS study, initial compliance was only 1%, whereas in the cur- 
ent study it was much higher at just under 50%. Secondly, the in- 
ospital mortality in both the public and private sector in the cur- 
ent study was low at 3.9- 4.4%, whereas the mortality of hospi- 
alised CAP patients reported in the BTS study was 8.8-13.6%. Mor- 
ality in the current study was highest in patients with a CURB- 
5 score ≥3 in both phases of the study, which is consistent with 
ther study findings [23 , 24] . 
In the current study, there was a low IV to oral switch pre- and
ost-intervention, particularly in the private sector. This needs fur- 
her investigation, although it may have been impacted by percep- 
ions regarding the criteria used by medical insurance companies 
or approval of admissions and level of care. Improvement in dose 
howed the least improvement but also had the highest compli- 
nce at baseline (91.5% to 94.2%). 
Admission of patients with a CURB-65 score of zero or one did 
ot improve from Phase 2 to Phase 4. The value of the scores, 
owever, was not the only admission criterion used. For example, 
f the score was low but the patient had a comorbidity, or social 
ircumstances that prevented home care, the admission would be 
onsidered appropriate. Furthermore, in HIV-positive patients, the 
resence of malnutrition and features of immunosuppression, such 
s oropharyngeal candidiasis may have swayed opinion to a more 
autious approach. As a result, a significant number of patients 
ho were classified in low CURB-65 categories, but had other cri- 
eria, were considered to have been admitted appropriately. Fur- 
her work is needed to improve admission criteria for more appro- 
riate use of health resources and level of treatment. 
There were several challenges, including gaps in research ex- 
erience and knowledge of systems improvement methodology 
mong SA pharmacists. In this regard, the current model included 
mplementation of a CAP bundle to improve compliance with 
uidelines, provided shared learning opportunities, and incorpo- 
ated ongoing expert support to ensure every participating phar- 
acist had the tools necessary to succeed. 
Such engagement with study leaders provided specific guidance 
egarding interventions and assisted with difficulties faced by phar- 
acists in the field. Pharmacists were taught how to calculate a 
URB-65 score and to review diagnostic and antibiotic steward- 
hip criteria to provide comprehensive interventions. The pharma- 
ists were also instructed how to use hospital-specific data and 
nformation from the overall study, to provide feedback to their 
wn stakeholders and team members and thus to create interdis- 
iplinary awareness of the existing system and potential for im- 
roved patient care. 8 Professional boundaries and hierarchies have been found to be 
ignificant barriers to antibiotic stewardship, particularly in LMICs 
25] . The current study reiterated the critical role of pharmacists 
rained in antibiotic stewardship as enablers of engagement be- 
ween multidisciplinary health care providers. Tailoring systems 
nd existing resources to support the key role of pharmacists in 
udit and feedback processes were successfully demonstrated. 
The current study has several limitations. The focus was to test 
 real-world, multi-hospital, cross sector, disease-specific, antibi- 
tic stewardship programme in SA using improved adherence to SA 
AP guidelines. It was not powered to show a difference in mortal- 
ty, LOS or IR-LOS. 
The study did not audit time to administration of first antibiotic 
ose relative to time of admission [21] because of inadequate doc- 
mentation; this may have impacted on any improvement in clin- 
cal outcomes. In addition, the study did not include collection of 
esults of microbiological data or determine aetiology of the pneu- 
onia. 
Due to the prospective nature of the study there was limited 
ime to implement interventions, as pharmacists were not dedi- 
ated researchers. However, in this real-world study of implemen- 
ation of stewardship measures in an LMIC, there was a demon- 
trated improvement in process outcomes. There was a large dif- 
erence in public and private representation as study leaders from 
he private sector had organisational leadership roles that enabled 
harmacist recruitment. Public-sector study leaders were based 
n academic centres and had to work through the hospital and 
rovincial structures for recruitment and were also hindered by 
elays in the provincial and individual hospital ethics approval 
imelines. It took 11 months for the protocol and ethics approval 
o be completed at each participating hospital, across the differ- 
nt provincial health departments and private hospital groups, a 
actor that needs urgent attention to facilitate other ASP inter- 
entions. More work is also required to increase participation of 
ublic-sector pharmacists in future studies. 
Resource constraints in both the public and private sector were 
ddressed by implementing the “allocated stewardship time” con- 
ept, which was verified by there being no significant difference 
n the average number of CAP patients reviewed per pharmacist in 
ither sector. 
A review of barriers to guideline implementation recommended 
hat structured implementation tailored to specific settings and 
arget groups could improve adherence [26] . Although the transfer 
f skills and behaviour changes was not formally investigated, the 
urrent study demonstrated that stewardship skills could be devel- 
ped through a combination of educational input, shared learning, 
nd testing in a real-world setting. Future studies to determine the 
arriers to guideline implementation in each sector and identify 
ehavioural determinants for successful interventions could sup- 
ort pharmacists to lead further improvements in compliance. 
The current study focused on the improvement in compliance 
o CAP guidelines; a more detailed review of the implementa- 
ion methods, i.e. how and why it works, as advocated in the call 
or more in-depth studies of the implementation of interventions, 
ould be valuable in future studies [27] . 
In conclusion, the unique success of the study was in demon- 
trating a successful pharmacist-led stewardship intervention 
n resource-constrained public-sector hospitals. In addition, the 
roundwork was set for disease-specific stewardship through a 
eal-world prospective study that bridged different aspects of stew- 
rdship in a coordinated, large-scale intervention in both public- 
nd private-sector hospitals. There is opportunity for frontline 
tewards across different settings, including LMICs, to collabo- 
ate in coordinated interventions and accelerate implementation of 
SPs through upskilling existing resources and enabling interdisci- 
linary engagement across health systems. 
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06189 . 9 esearch in context panel 
vidence before this study 
Google Scholar and PubMed were searched for relevant stud- 
es published in English up to January 30, 2020, using the terms 
community acquired pneumonia”, “CAP”, “guidelines”; “pharma- 
ist or specialized pharmacists”, “public and private hospitals”
ND “antibiotic or antimicrobial stewardship”, “diagnostic stew- 
rdship”; “LMICs”, “multicentre”, ”implementation”, “compliance”, 
antibiotic stewardship training and skills”. Additional studies were 
dentified from the authors’ personal reference lists and refer- 
nce lists from articles that were retrieved. Studies were ex- 
luded if they did not describe antimicrobial stewardship (AMS) 
nterventions in hospital in-patient settings or did not refer to 
harmacists. 
Surveys of implementation of antimicrobial stewardship pro- 
rammes (ASPs) in hospitals frequently revealed considerable vari- 
tion in scope and scale of programmes with most published stud- 
es being from ur0062an-academic settings in high resource coun- 
ries. The latest Cochrane systematic review of interventions to im- 
rove antimicrobial prescribing included 221 studies, of which 183 
83%) were from Europe and North America and none were from 
frica. There is a growing call for effective models to implement 
SPs in low and middle-income countries (LMICs) and for support 
o enable interventions by front-line stewards in different hospi- 
al settings to be collated, evaluated and submitted for publication. 
he need to incorporate pharmacists as an essential member of 
SPs in hospitals is acknowledged, yet progress in LMICs has been 
imited by a lack in pharmacist resources and training in infectious 
iseases (ID) and AMS. 
Although the current search revealed some surveys of ASP 
cross public- and private-sector hospitals, there were no inter- 
entional collaborative AMS studies across both sectors in LMICs. 
hus, no literature is available globally on pharmacist-led, multi- 
entre, collaborative, antibiotic stewardship initiatives across both 
ublic and private healthcare sectors in geographically disparate 
ettings. Regarding community-acquired pneumonia (CAP), im- 
lementation of care bundles and guidelines were reported to 
ave the potential to impact on process of care and clinical 
utcomes. 
dded value of this study 
This is the first national South African (SA) pharmacist-led mul- 
icentre collaborative AMS initiative across both public and pri- 
ate healthcare sectors. Although we previously demonstrated that 
ur AMS model could be implemented across 47 SA hospitals us- 
ng pharmacists without ID training, all the hospitals were private 
ospitals; therefore, it was imperative to have representation from 
oth public and private hospitals because 80% of health care deliv- 
ry in SA is via the public sector. 
Disease-specific guidelines were used for the first time (in 
his case the SA CAP guidelines) and the same methodology 
nd model for stewardship interventions was used to initiate 
n ASP across both sectors. An increase in overall CAP bun- 
le compliance was demonstrated as well as improved diag- 
ostic and antibiotic stewardship compliance with no difference 
etween public- and private-sector hospitals. AMS skills were 
ransferred to public-sector pharmacists who had not partici- 
ated in AMS before in a setting where they face even more 
ntense human resource and health system challenges than col- 
eagues in the private sector. The ASP was also extended to in- 
lude new private-sector hospitals with no previous stewardship 
xperience. 



























To strengthen implementation and scalability of ASPs across 
ublic and private hospitals, health systems in LMICs may benefit 
rom the methodology of shared learning and upskilling of non- 
pecialised pharmacists in collaborative interventions, such as this 
ocused disease-specific improvement initiative. Opportunities for 
rontline stewards across different settings to collaborate in coor- 
inated interventions have the potential to accelerate implemen- 
ation of ASPs through upskilling existing resources and enabling 
nterdisciplinary engagement across health systems. 
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